Cutaneous Eruptions Associated With Androgen Receptor Inhibitors for Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled Trials

被引：0
作者：
Ahmad, Ihtisham [1 ]
Sood, Siddhartha [1 ]
Al-Daqqaq, Zizo [1 ]
Bagit, Ahmed [1 ]
Maliyar, Khalad [2 ]
Mufti, Asfandyar [2 ,3 ]
Yeung, Jensen [2 ,3 ,4 ,5 ,6 ]
机构：
[1] Univ Toronto, Temerty Fac Med, Toronto, ON, Canada
[2] Univ Toronto, Dept Med, Div Dermatol, Toronto, ON, Canada
[3] Sunnybrook Hlth Sci Ctr, Dept Dermatol, Toronto, ON, Canada
[4] Womens Coll Hosp, Dept Dermatol, Toronto, ON, Canada
[5] Prob Med Res, Waterloo, ON, Canada
[6] Womens Coll Hosp, Div Dermatol, 76 Grenville St,5th Floor, Toronto, ON M5S 1B2, Canada
来源：
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY | 2024年 / 28卷 / 04期
关键词：
cutaneous eruption; meta-analysis; prostate cancer; androgen receptor inhibitor; adverse event; drug eruption;
D O I：
10.1177/12034754241239278
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：395 / 396
页数：2
相关论文
共 50 条
  • [41] Anemia is associated with poor outcomes of metastatic castration-resistant prostate cancer, a systematic review and meta-analysis
    Dai, Dongjun
    Han, Shuting
    Li, Ling
    Guo, Yan
    Wei, Yuping
    Jin, Hongchuan
    Wang, Xian
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2018, 10 (12): : 3877 - 3886
  • [42] The Link Between Androgen Receptor Splice Variants and Castration-Resistant Prostate Cancer
    Cynthia C. T. Sprenger
    Stephen R. Plymate
    Hormones and Cancer, 2014, 5 : 207 - 217
  • [43] Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic
    Imamura, Yusuke
    Sadar, Marianne D.
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (08) : 654 - 665
  • [44] Genistein resists castration-resistant prostate cancer by inhibiting the androgen receptor pathway
    Yu, Xiao-Ping
    Zheng, Lu-Jie
    Yan, Jia-Li
    Luo, Yan
    Song, Xiao-Long
    Fu, Tian-Yu
    Peng, Xiao-Li
    Du, Jing-Chang
    Han, Bin
    Li, Fei
    Zhu, Yan-Feng
    JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 2025,
  • [45] The association between androgen receptor splice variant 7 status and prognosis of metastatic castration-resistant prostate cancer: A systematic review and meta-analysis
    Zhou, Jiatong
    Liu, Ranlu
    ANDROLOGIA, 2020, 52 (07)
  • [46] Docetaxel-based therapy with and without antiangiogenic agents as first-line chemotherapy for castration-resistant prostate cancer: A meta-analysis of nine randomized controlled trials
    Lei, Naijun
    Song, Zhengfang
    Lu, Bing
    Tan, Zheng
    Pei, Jiao
    Liu, Wusong
    Xu, Ke
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (06) : 1182 - 1188
  • [47] Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer
    Shiota, Masaki
    Yokomizo, Akira
    Naito, Seiji
    FREE RADICAL BIOLOGY AND MEDICINE, 2011, 51 (07) : 1320 - 1328
  • [48] MicroRNA Regulation of Androgen Receptor in Castration-Resistant Prostate Cancer: Premises, Promises, and Potentials
    Ebrahimi, Safieh
    Hashemy, Seyed Isaac
    Sahebkar, Amirhossein
    Aghaee-Bakhtiari, Seyed Hamid
    CURRENT MOLECULAR PHARMACOLOGY, 2021, 14 (04) : 559 - 569
  • [49] Current Status of Monoclonal Antibodies-Based Therapies in Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis of Clinical Trials
    Tarrar, Talha Azam
    Anwar, Muhammad Yasir
    Ali, Muhammad Ashar
    Saeed, Memoona
    Rehman, Sana
    Bajwa, Shammas F.
    Ayub, Tooba
    Javid, Haleema
    Ali, Rimsha
    Irshad, Alaa
    Aiman, Wajeeha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (03)
  • [50] Experimental Evidence of Persistent Androgen-Receptor-Dependency in Castration-Resistant Prostate Cancer
    Kobayashi, Takashi
    Inoue, Takahiro
    Kamba, Tomomi
    Ogawa, Osamu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (08): : 15615 - 15635
12345